Next Article in Journal
Food Habits of Older Australians Living Alone in the Australian Capital Territory
Previous Article in Journal
Comparison of the Effects of Visual and Auditory Distractions on Fistula Cannulation Pain among Older Patients Undergoing Hemodialysis: A Randomized Controlled Clinical Trial
Article

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center

1
Chase Family Movement Disorders Center, Hartford HealthCare, Hartford, CT 06066, USA
2
Hartford Neurology LLC, Hartford, CT 06066, USA
3
Ayer Neuroscience Institute, Hartford HealthCare, Hartford, CT 06066, USA
*
Author to whom correspondence should be addressed.
Geriatrics 2020, 5(3), 54; https://doi.org/10.3390/geriatrics5030054
Received: 26 August 2020 / Revised: 15 September 2020 / Accepted: 15 September 2020 / Published: 18 September 2020
(This article belongs to the Section Geriatric Neurology)
It is not established whether SARS-CoV-2 (COVID-19) patients with movement disorders, are at greater risk for more serious outcomes than the larger COVID-19 population beyond the susceptibility associated with greater age. We reviewed electronic health records and conducted telephone interviews to collect the demographics and clinical outcomes of patients seen at our Movement Disorders Center who tested positive for COVID-19 from 8 March 2020 through 6 June 2020. Thirty-six patients were identified, 23 men and 13 women, median age of 74.5 years. They primarily carried diagnoses of idiopathic Parkinson disease (n = 22; 61%) and atypical parkinsonism (n = 7; 19%) with the balance having other diagnoses. Twenty-seven patients (75%) exhibited alteration in mental status and fifteen (42%) had abnormalities of movement as common manifestations of COVID-19; in 61% and 31%, respectively, these were the presenting symptoms of the disease. Sixty-seven percent of patients in our cohort required hospitalization, and the mortality rate was 36%. These data demonstrate that in patients with movement disorders, the likelihood of hospitalization and death after contracting COVID-19 was greater than in the general population. Patients with movement disorders frequently presented with altered mental status, generalized weakness, or worsening mobility but not anosmia. View Full-Text
Keywords: coronavirus; COVID-19; neurology; movement disorders; ataxia; adamantanes; Parkinson disease coronavirus; COVID-19; neurology; movement disorders; ataxia; adamantanes; Parkinson disease
Show Figures

Figure 1

MDPI and ACS Style

de Marcaida, J.A.; Lahrmann, J.; Machado, D.; Bluth, L.; Dagostine, M.; Moro-de Casillas, M.; Bortan, E.; Kanchana, S.; Alberts, M. Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center. Geriatrics 2020, 5, 54. https://doi.org/10.3390/geriatrics5030054

AMA Style

de Marcaida JA, Lahrmann J, Machado D, Bluth L, Dagostine M, Moro-de Casillas M, Bortan E, Kanchana S, Alberts M. Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center. Geriatrics. 2020; 5(3):54. https://doi.org/10.3390/geriatrics5030054

Chicago/Turabian Style

de Marcaida, Joy A., Jeffrey Lahrmann, Duarte Machado, Lawrence Bluth, Michelle Dagostine, Maria Moro-de Casillas, Elena Bortan, Sulada Kanchana, and Mark Alberts. 2020. "Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center" Geriatrics 5, no. 3: 54. https://doi.org/10.3390/geriatrics5030054

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop